Tenure track assistant Professor in Immunopeptidomics and Antigen Discovery

UNIL is a leading international teaching and research institution, with over 5,000 employees and 15,500 students split between its Dorigny campus, CHUV and Epalinges. UNIL and CHUV encourage excellence, individual recognition and responsibility. The Faculty of Biology and Medicine (FBM) and the Lausanne University Hospital (CHUV) are inviting applications for a position of:

Tenure track assistant Professor toward associate Professor

 in Immunopeptidomics and Antigen Discovery

within the Department of Oncology

The CHUV and UNIL are seeking to recruit a scientist with a highly recognized expertise in antigen discovery and proteogenomics-driven mass spectrometry based immunopeptidomics. The position will consist of running the Immunopeptidomics Unit in the Lausanne Branch of the Ludwig Institute for Cancer Research at UNIL/CHUV and the Center for Experimental Therapeutics (CTE), to support with advanced antigen discovery work the development of personalized cancer therapies.

Main missions:

• Run and supervise a research laboratory with activities focused on mass spectrometry and proteo-genomics driven antigen discovery, embracing both fundamental and translational research.

• Develop research activities on computational pipelines for prediction and prioritization of targets for cancer vaccines and T cell based therapies.

• Responsible the implementation of analytical and computational procedures in exploratory clinical trials following GCLP and ethics requirements as part of the clinical mission at the CTE

• Develop pre and postgraduate teaching activities on the biology of antigen processing and presentation and the application of immunopeptidomics and prediction pipelines for antigen discovery.

Desired profile:

• PhD degree with world-class expertise in mass spectrometry based immunopeptidomics applied to cancer research.
• Outstanding research track record in immunopeptidomics, proteogenomics and discovery of novel cancer antigens.
• Expertise in development of innovative computational tools for antigen prediction and prioritization leveraging large-scale immunopeptidomics dataset
• Be able to demonstrate leadership in driving clinical applications and collaborations with national and international research groups
• Strong leader skills to run and oversee an interdisciplinary translational research laboratory group.
• Successful exampležs of clinical translation for cancer immunotherapy.
• Willingness to translate proteogenomics and immunopeptidomics research into clinical activities
• Experience of teaching immunopeptidomics and (neo) antigen discovery at an international level.
• Previous experience with setting up mass spectrometry lab – an advantage
• Experience in obtaining external competitive research grants
• High-quality publications in peer reviewed journals
• Strong communication skills

Further information may be obtained from Prof. George Coukos (george.coukos@chuv.ch), Head of the oncology Department.

Applications, in English, will include a motivation letter, a curriculum vitae, a copy of the five most relevant publications, as well as names and contact information of three referees, a brief statement of research interests and teaching experience and a copy of diplomas. They should be submitted online by January 24^th 2021 (23:59 GMT+1) to wwwfbm.unil.ch/releve/application/ as a single PDF file.

The job description is available on the same link.

We offer a pleasant working atmosphere in a multicultural, diverse and dynamic academic environment. There are possibilities for continuing professional education and a multitude of activities and other benefits to discover.

UNIL and CHUV are committed to promoting gender equality and diversity and strongly encourage applications from female candidates. www.unil.ch/egalite